Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 2.

Proceedings Paper

Helliwell, P, Lespessailles, E, Shuler, C et al. (4 more authors) (2018) Ixekizumab Provides Sustained Improvement in Signs and Symptoms in Patients with Active Psoriatic Arthritis: Two-Year Results from a Phase 3 Trial. In: Journal of Rheumatology. 73rd Annual Meeting of The Canadian-Rheumatology-Association (CRA), 21-24 Feb 2018, Vancouver, Canada. Journal of Rheumatology Publishing Co., Ltd. , pp. 998-999.

Chandran, V, Fleischmann, R, Lespessailles, E et al. (4 more authors) (2018) Efficacy and safety of ixekizumab in patients with active psoriatic arthritis: three year results from a phase 3 study (SPIRIT-P1). In: Acta Dermato-Venereologica. 5th World Psoriasis & Psoriatic Arthritis Conference, 27-30 Jun 2018, Stockholm, Sweden. Society for Publication of Acta Dermato-Venereologica , pp. 23-24.

This list was generated on Sun Oct 20 11:15:23 2019 BST.